MCE - Delayed Quote EUR

Oryzon Genomics S.A. (ORY.MC)

Compare
1.5200
-0.0040
(-0.26%)
At close: January 10 at 5:35:17 PM GMT+1

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue --
Earnings -1.28M
Q4'23
Q1'24
Q2'24
Q3'24
-2M
-1M
-500K
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

2.00
6.17 Average
1.5200 Current
12.00 High

Earnings Estimate

Currency in EUR Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1144
Avg. Estimate -0.01-0.01-0.050.05
Low Estimate -0.01-0.01-0.06-0.15
High Estimate -0.01-0.01-0.030.44
Year Ago EPS -0.03-0.02-0.06-0.05

Revenue Estimate

Currency in EUR Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1144
Avg. Estimate ----4.15M13.38M
Low Estimate --------
High Estimate ----9M40.5M
Year Ago Sales ------4.15M
Sales Growth (year/est) 0.00%0.00%0.00%222.29%

Earnings History

Currency in EUR 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -0.03-0.03-0.01-0.02
EPS Actual -0.03-0.020-0.02
Difference -00.010.01-0
Surprise % -2.41%33.71%100.00%-2.89%

EPS Trend

Currency in EUR Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -0.01-0.01-0.050.05
7 Days Ago -0.020-0.050.03
30 Days Ago -0.020-0.050.03
60 Days Ago -0.020-0.050.03
90 Days Ago -0.02-0.02-0.07-0.01

EPS Revisions

Currency in EUR Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days 1----1
Up Last 30 Days 1--22
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ORY.MC 63.83%46.12%9.93%191.33%
S&P 500 8.70%11.55%14.03%13.42%

Related Tickers